Centiva Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,000
Closed -$138K 2159
2026
Q1
$138K Hold
18,000
﹤0.01% 1345
2025
Q4
$175K Buy
+18,000
New +$153K ﹤0.01% 1009
2025
Q3
Sell
-74,253
Closed -$474K 1723
2025
Q2
$690K Buy
+74,253
New +$648K 0.01% 799
2024
Q3
Sell
-11,134
Closed -$100K 2523
2024
Q2
$100K Buy
+11,134
New +$77.6K ﹤0.01% 1854

Other funds holding REPL

Centiva Capital's REPL Position: Q2 2026 in Review

Centiva Capital sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 18,000 shares — an estimated $138K sold.

Centiva Capital first reported a position in REPL in Q2 2024 and held it in 4 quarters. The position peaked at $690K in Q2 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Centiva Capital reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 18,000 Replimune Group shares in Q2 2026, an estimated $138K.
  • Centiva Capital first reported a position in Replimune Group in Q2 2024 and held it in 4 quarters.
  • Centiva Capital's Replimune Group position peaked at $690K in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.